🔗 Share this article Users Discontinuing Slimming Jabs Regain Pounds at a Quadrupled Rate Compared to People Using Diet and Exercise Obesity treatment often requires long-term strategies. New research reveals that individuals who discontinue new GLP-1 drugs like Mounjaro or Wegovy tend to recover shed pounds far faster than those who halt conventional lifestyle plans. Research printed in a major medical journal shows that while overweight individuals frequently drop substantial amounts of their body weight while undergoing treatment, the mass comes back at an estimated rate of 0.8 kg per month once they quit. "Individuals purchasing such drugs need to be aware of the danger of rapid weight regain when the medication is stopped," cautioned lead investigator Dr. Susan Jebb. Such speed of regain means a return to original weight within about a year and a half. Comparing Therapies The research, which examined dozens of trials involving over 9,000 of participants, compared the outcomes of the injectable medications with other pills. The team point out that individuals who shed pounds through lifestyle changes alone generally have a less rapid creep back—around 0.1 kg a month—once they finish. Understanding the Fast Regain Experts propose the mode of action of the jabs explains the accelerated rebound. The injections mimic a natural hormone called glucagon-like peptide-1, which moderates feelings of fullness. "Long-term administration of GLP-1 levels several times higher than normal might result in the body to produce less of its endogenous hormone, and may also lessen responsiveness to its actions," said Dr. Adam Collins, a nutrition expert. "Withdrawal of this hormone supplement leads to appetite is no longer kept in check, making binge eating a significant risk." A Chronic Disease? Health authorities recommend the injections for individuals with obesity-related medical conditions, accompanied by recommended diet and exercise modifications. A number of clinicians argue that, considering the high risk of relapse, the treatment is often life-long. This opinion is reinforced by pharmaceutical companies, who say that the findings "underscore the chronic nature of excess weight," comparing it to managing conditions like diabetes. User Testimonies Users who have discontinued the jabs describe a sudden resurgence of cravings. "It felt as if something activating and I was suddenly ravenous," described one woman. This challenge is compounded if users have not established sustainable lifestyle or habit modifications during therapy. Growing Adoption Recent estimates show that millions of adults in the UK have used weight-loss jabs in the past year, with interest continuing to grow. Adoption is more common among females compared to men. The 40s and 50s age group shows the highest usage rates. A large proportion access the drugs through private healthcare rather than public health services. Finally, experts stress that while these medications are potent agents for weight loss, they are not a magic solution and lasting health benefits relies on combined lifestyle management.
Obesity treatment often requires long-term strategies. New research reveals that individuals who discontinue new GLP-1 drugs like Mounjaro or Wegovy tend to recover shed pounds far faster than those who halt conventional lifestyle plans. Research printed in a major medical journal shows that while overweight individuals frequently drop substantial amounts of their body weight while undergoing treatment, the mass comes back at an estimated rate of 0.8 kg per month once they quit. "Individuals purchasing such drugs need to be aware of the danger of rapid weight regain when the medication is stopped," cautioned lead investigator Dr. Susan Jebb. Such speed of regain means a return to original weight within about a year and a half. Comparing Therapies The research, which examined dozens of trials involving over 9,000 of participants, compared the outcomes of the injectable medications with other pills. The team point out that individuals who shed pounds through lifestyle changes alone generally have a less rapid creep back—around 0.1 kg a month—once they finish. Understanding the Fast Regain Experts propose the mode of action of the jabs explains the accelerated rebound. The injections mimic a natural hormone called glucagon-like peptide-1, which moderates feelings of fullness. "Long-term administration of GLP-1 levels several times higher than normal might result in the body to produce less of its endogenous hormone, and may also lessen responsiveness to its actions," said Dr. Adam Collins, a nutrition expert. "Withdrawal of this hormone supplement leads to appetite is no longer kept in check, making binge eating a significant risk." A Chronic Disease? Health authorities recommend the injections for individuals with obesity-related medical conditions, accompanied by recommended diet and exercise modifications. A number of clinicians argue that, considering the high risk of relapse, the treatment is often life-long. This opinion is reinforced by pharmaceutical companies, who say that the findings "underscore the chronic nature of excess weight," comparing it to managing conditions like diabetes. User Testimonies Users who have discontinued the jabs describe a sudden resurgence of cravings. "It felt as if something activating and I was suddenly ravenous," described one woman. This challenge is compounded if users have not established sustainable lifestyle or habit modifications during therapy. Growing Adoption Recent estimates show that millions of adults in the UK have used weight-loss jabs in the past year, with interest continuing to grow. Adoption is more common among females compared to men. The 40s and 50s age group shows the highest usage rates. A large proportion access the drugs through private healthcare rather than public health services. Finally, experts stress that while these medications are potent agents for weight loss, they are not a magic solution and lasting health benefits relies on combined lifestyle management.